German vaccine company CureVac says no offers from Trump to buy exclusive vaccine access

Pressure to create a coronavirus vaccine is increasing by the day, but for a safe vaccine to enter the market, it takes time. USA TODAY

A German biotech company tweeted Monday it did not receive an offer from President Trump for rights to a coronavirus vaccine it is working on.

The statement was aimed at putting an end to controversy surrounding a reported attempt by Trump to gain exclusive access to a potential coronavirus vaccine, or the German research group doing work on it. On Monday the White House also dismissed the charge. 

The controversy broke Sunday when the German newspaper Die Welt am Sonntag published a story saying Trump offered a large sum of money to the company at a meeting on March 2 in exchange for obtaining the vaccine when and if it were developed.

The headline read, “Donald Trump grabs for German Vaccine Company."

Citing government sources, the newspaper reported “there is talk of a billion dollars in Berlin.”

The report also said Trump wanted CureVac to move its research group to the United States from Tübingen, the southern German town where the company is based. The company has offices in Boston but its main research is not carried out there.

German Health Ministry officials confirmed to Reuters on Sunday that the article was correct but that Germany was working to ensure any vaccines would be available to all.

“Capitalism has limits,” tweeted Karl Lauterbach, a member of the German Bundestag and a professor of health economics and epidemiology.

By Monday, the White House had dismissed the charge, CureVac said it had no offer from the United States and the German government was meeting about the issue. White House aides told the Washington Post Monday they were aware of no offer from Trump to CureVac.

CureVac's majority shareholder said Monday “it was not an option” for the company to develop the vaccine exclusively for the United States.

“It goes without saying that it cannot be that a German company develops the vaccine and that it is used exclusively in the USA,” Dietmar Hopp told the German newspaper Suddeutsche Zeitung on Monday.

CureVac issued a news release on March 3 announcing that its CEO, Daniel Menichella, was invited to the White House to discuss vaccine development with Trump and members of the White House Coronavirus Task Force, together with other companies working on vaccines.

Menichella left the company abruptly five days ago. A CureVac news release gave no reason for his departure.

CureVac’s focus is on messenger RNA-based vaccines and cancer therapies. RNA is what genes use to tell cells which proteins to assemble. Such a vaccine could carry a non-infective blueprint of the coronavirus protein, triggering the production of antibodies that would give the person getting vaccinated immunity from the disease.


News Related


Trump’s ‘mission accomplished’ moment is premature and deadly. We have not defeated COVID.

Desperate for crowds and adoration, Trump has put his most fervent supporters at risk of getting a deadly disease. Future historians will be astonished. Read more »

NFLPA president JC Tretter says NFL is putting season, players at risk with its coronavirus approach

NFL Players Association president JC Tretter said Tuesday the NFL is putting the 2020 season at risk with its coronavirus approach, calling on the league to better “prioritize player safety.” “Like many other... Read more »

Brazilian President Jair Bolsonaro says he tested positive for the coronavirus

RIO DE JANEIRO (AP) — Brazil’s President Jair Bolsonaro says he has tested positive for COVID-19 after months of downplaying the virus’ severity. Bolsonaro confirmed the test results while wearing a mask and... Read more »

Venice Film Festival forges ahead amid COVID-19 pandemic with reduced lineup

The show will go on for the Venice Film Festival in September, but with a few modifications due to the COVID-19 pandemic. Organizers said Tuesday that they are pushing forward with plans for... Read more »

Amtrak offers buy-one, get-one promotion on its sleeper trains amid COVID-19 — with a catch

Amtrak wants you to have sweet dreams the next time you travel — so much so that it’s sweetening the deal on its sleeper “roomettes.” The rail service is offering a buy-one-get-one-free discount... Read more »

Florida teen treated with hydroxychloroquine at home before dying of COVID-19, report says

FORT MEYERS, Fla. – The family of a 17-year-old Florida girl who died last month from COVID-19 treated her symptoms at home for nearly a week before taking her to a hospital, a... Read more »

Mookie Betts worried MLB coronavirus testing woes could prevent him from ever playing for Dodgers

During nearly four months away from the game, Mookie Betts said he “stayed away from baseball to keep myself sane.” It’s not hard to understand why. The 2018 American League Most Valuable Player... Read more »

Tom Hanks doesn’t get ‘how common sense has somehow been put into question’ with coronavirus

Read more »

Can Gov. DeSantis force Florida schools to reopen amid the coronavirus pandemic? Some school leaders seem doubtful.

PALM BEACH, Fla. — As concern about the state order spread online, some school leaders said: Not so fast. As Florida educators puzzle over how to start the new academic year, Gov. Ron... Read more »

Texas surpasses 200,000 coronavirus cases after 4th of July holiday weekend

AUSTIN, Texas – Texas reached 200,000 total COVID-19 cases Monday, just 17 days after crossing the 100,000 threshold, a figure that took the state nearly four months to hit. The grim milestone came... Read more »